Close Menu


News on in vitro diagnostics for gastrointestinal disease.

ArcDia will provide Xinhua its biochemical assay components and R&D services in order to localize the Finnish firm's MariPOC testing platform in China.

The firm lowered topline and non-GAAP earnings per share guidance for fiscal 2019.

By achieving certification for the assay, called PredictSure IBD, the Cambridge, UK-based firm can sell it for clinical use across Europe.

Researchers hope that understanding the etiology of inappropriate testing will help them design a better computerized support tool.

The spinout of the University of California, Davis Foods For Health Institute intends the test to be used at the point of care in pediatrician's offices.